TY - JOUR T1 - Trabectedin for the treatment of relapsed ovarian cancer JO - Health Technology Assessment PY - 2011/05/01 AU - Papaioannou D AU - Rafia R AU - Stevenson MD AU - Stevens JW AU - Evans P ED - DO - DOI: 10.3310/hta15suppl1-08 PB - National Institute for Health Research VL - 15 IS - Suppl 1 SP - 69 EP - 75 Y2 - 2025/05/31 ER -